Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

11.50 +0.40 (+3.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 36,633
Open 10.80
Bid (Size) 10.10 (2)
Ask (Size) 12.22 (2)
Prev. Close 11.10
Today's Range 10.17 - 12.22
52wk Range 6.149 - 739.20
Shares Outstanding 23,341,336
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-88.4%
-88.4%
1 Month
+38.7%
+38.7%
3 Month
-19.8%
-19.8%
6 Month
-94.6%
-94.6%
1 Year
-95.5%
-95.5%

More News

Read More
These stocks are gapping in today's session
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Appoints RNAi Pioneer Phillip Zamore to Scientific Advisory Board
Via Investor Brand Network
Which stocks are experiencing notable movement on Monday?
Via Chartmill
Top stock movements in today's session.
Via Chartmill
InvestorNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances RNA Cancer Therapy as 15 Patients Dosed in Phase 1a Trial
Via Investor Brand Network
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Sets 1-for-28 Reverse Stock Split Effective May 15
Via Investor Brand Network
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
Via Benzinga
Topics Stocks World Trade
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside
Via Stocktwits
Topics Stocks
Here are the top movers in Thursday's session.
Via Chartmill
These stocks are making the most noise in today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
Via Chartmill
BioMedNewsBreaks — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138
Via Investor Brand Network

Frequently Asked Questions

Is TransCode Therapeutics, Inc. - Common Stock publicly traded?
Yes, TransCode Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does TransCode Therapeutics, Inc. - Common Stock trade on?
TransCode Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TransCode Therapeutics, Inc. - Common Stock?
The ticker symbol for TransCode Therapeutics, Inc. - Common Stock is RNAZ on the Nasdaq Stock Market
What is the current price of TransCode Therapeutics, Inc. - Common Stock?
The current price of TransCode Therapeutics, Inc. - Common Stock is 11.50
When was TransCode Therapeutics, Inc. - Common Stock last traded?
The last trade of TransCode Therapeutics, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of TransCode Therapeutics, Inc. - Common Stock?
The market capitalization of TransCode Therapeutics, Inc. - Common Stock is 268.43M
How many shares of TransCode Therapeutics, Inc. - Common Stock are outstanding?
TransCode Therapeutics, Inc. - Common Stock has 268M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.